Multimodality Treatment of Pancreatic Cancer With Liver Metastases Using Chemotherapy, Radiation Therapy, and/or Chinese Herbal Medicine
暂无分享,去创建一个
Zhongxing Liao | Zhiqiang Meng | Peng Wang | Lorenzo Cohen | Z. Liao | Zhen Chen | Z. Meng | Peng Wang | Luming Liu | L. Cohen | D. Chang | Luming Liu | Zhen Chen | Huaqiang Ouyang | Er’xin Yu | Huan Jin | David Z. Chang | Huan Jin | H. Ouyang | E. Yu
[1] A. Cull,et al. Chemotherapy prolongs survival in inoperable pancreatic carcinoma , 1994, The British journal of surgery.
[2] Gemcitabine plus Bevacizumab no better than Gemcitabine alone in Clinical Study of 600 Patients with Pancreatic Cancer , 2007, Cancer biology & therapy.
[3] Wen-Zhi Chen,et al. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. , 2005, Radiology.
[4] Irving Waxman,et al. A multispecialty approach to the diagnosis and management of pancreatic cancer , 2000, American Journal of Gastroenterology.
[5] T. Linné,et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] J. Bruix,et al. Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients , 1990, Hepatology.
[7] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[8] H. Ueno,et al. Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy , 2001, Cancer.
[9] M. Fuss,et al. Multimodality Approaches for Pancreatic Cancer , 2005, CA: a cancer journal for clinicians.
[10] H. Friess,et al. Pancreatic Resection for M1 Pancreatic Ductal Adenocarcinoma , 2006, Annals of Surgical Oncology.
[11] F. Gay,et al. Prognostic Factors and Prognostic Index for Chemonaïve and Gemcitabine-Refractory Patients with Advanced Pancreatic Cancer , 2008, Oncology.
[12] H. Ohigashi,et al. [Chemotherapy for adenocarcinoma of the pancreas]. , 1997, Nihon Geka Gakkai zasshi.
[13] S. Green,et al. Gemcitabine Plus Celecoxib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma: Results of a Phase II Trial , 2008, American journal of clinical oncology.
[14] J. Tward,et al. Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: Results of a study from the surveillance, epidemiology, and end results (SEER) registry data , 2007, Cancer.
[15] T. Kamigaki,et al. Impact of Gemcitabine on the Survival of Patients With Stage IV Pancreatic Cancer , 2007, Pancreas.
[16] H. Friess,et al. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. , 2008, American journal of surgery.
[17] G. Colucci,et al. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma , 2002, Cancer.
[18] Schnall Sf,et al. Chemotherapy of adenocarcinoma of the pancreas. , 1996 .
[19] C. Ko,et al. Multimodality therapy for pancreatic cancer in the U.S. , 2007, Cancer.
[20] M. Choti,et al. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? , 2007, Cancer.
[21] D. Rubin,et al. The Long-term Survival of a Patient With Pancreatic Cancer With Metastases to the Liver After Treatment With the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol , 2006, Integrative cancer therapies.
[22] S. H. Lee,et al. Survival and Prognostic Factors of Unresectable Pancreatic Cancer , 2008, Journal of clinical gastroenterology.
[23] Jacques Ferlay,et al. Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.
[24] H. Ueno,et al. Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy. , 2008, Japanese journal of clinical oncology.
[25] H. Ueno,et al. A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer , 2008, Cancer Chemotherapy and Pharmacology.
[26] Douglas B. Evans,et al. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation , 2006, Cancer.
[27] A. Dachman,et al. Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Jeffrey E. Lee,et al. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. , 2005, Archives of surgery.
[29] K. Rückert,et al. Surgical treatment of pancreatic cancer , 1984, World Journal of Surgery.
[30] J. Jeekel,et al. Adjuvant 5-FU-Based Chemoradiotherapy for Patients Undergoing R-1/R-2 Resections for Pancreatic Cancer , 2005, Digestive Surgery.
[31] J. Cameron,et al. One Thousand Consecutive Pancreaticoduodenectomies , 2006, Annals of surgery.
[32] J. Furuse,et al. Hepatic arterial infusion of 5-fluorouracil and extrabeam radiotherapy for liver metastases from pancreatic carcinoma. , 2004, Hepato-gastroenterology.